Development of persistent headache following stroke: A 3-year follow-up

被引:37
|
作者
Hansen, Anne P. [1 ]
Marcussen, Ninna S. [1 ]
Klit, Henriette [1 ]
Kasch, Helge [2 ,3 ]
Jensen, Troels S. [1 ,3 ]
Finnerup, Nanna B. [1 ]
机构
[1] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Headache Clin, DK-8000 Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark
关键词
Post-stroke headache; prospective study; medication overuse; dipyridamole; tension-type headache; ISCHEMIC-STROKE; DIPYRIDAMOLE; IMPACT; ONSET; PAIN; EPIDEMIOLOGY; TRANSIENT; MIGRAINE; OVERUSE; SCALE;
D O I
10.1177/0333102414545894
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Headache following stroke has been described in previous studies with an incidence of 23%-54%, but a clear description of headache developing after stroke onset is still lacking. The aim of this study was to determine the incidence and characteristics of persistent novel headache after stroke and to describe the use of medication, including dipyridamole. Methods As a follow-up to a prospective study, a standardized questionnaire about characteristics of novel headache and medication use was sent out to surviving patients three years after their stroke. Results The questionnaire was sent to 256 patients and returned by 222, of whom 12% (26/222) of patients reported persistent novel headache. Dipyridamole had no significant influence on the incidence. Stroke-attributed headache according to predefined criteria was reported in 7.2% (16/222) of patients, with tension-type-like headache in 50.0%, migraine-like in 31.3% and medication overuse in 6.25% of patients. More than half of patients experienced moderate to severe pain and had a score of 55 or above on the Headache Impact Test-6 scale. Conclusion Novel headache after stroke affects one in 10 patients and seems to be unrelated to dipyridamole use. Persistent headache attributed to stroke is similar to tension-type headache for half of patients.
引用
收藏
页码:399 / 409
页数:11
相关论文
共 50 条
  • [31] Facial allotransplantation: A 3-year follow-up report
    Diaz-Siso, J. Rodrigo
    Parker, Melanie
    Bueno, Ericka M.
    Sisk, Geoffroy C.
    Pribaz, Julian J.
    Eriksson, Elof
    Annino, Donald
    Tullius, Stefan G.
    Pomahac, Bohdan
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (11): : 1458 - 1463
  • [32] 3-YEAR FOLLOW-UP DATA IN OVERWEIGHT TREATMENT
    HAUTZINGER, M
    JOURNAL OF CLINICAL PSYCHOLOGY, 1980, 36 (02) : 530 - 533
  • [33] Alberta euthanasia survey: 3-year follow-up
    Verhoef, MJ
    Kinsella, TD
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 155 (07) : 885 - 890
  • [34] BRIGHT DELINQUENTS - 3-YEAR FOLLOW-UP STUDY
    TENNENT, G
    GATH, D
    BRITISH JOURNAL OF CRIMINOLOGY, 1975, 15 (04): : 386 - 390
  • [35] A 3-year follow-up of the Silent Diabetes Study
    Oliver Schnell
    Rolf Doerr
    Volker Lodwig
    Joerg Weissmann
    Tobias Lohmann
    Diabetologia, 2014, 57 : 2596 - 2598
  • [36] Indinavir, zidovudine, lamivudine: 3-year follow-up
    Dworkin, MS
    Wan, PCT
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (02) : 165 - 165
  • [37] A 3-year follow-up study of 'orientation agnosia'
    Fujinaga, N
    Muramatsu, T
    Ogano, M
    Kato, M
    NEUROPSYCHOLOGIA, 2005, 43 (08) : 1222 - 1226
  • [38] DEVELOPMENT OF BONEMINERAL DENSITY IN ADOLESCENT: A PROSPECTIVE 3-YEAR FOLLOW-UP STUDY
    Menshikova, L.
    Menshikov, A.
    Maksikova, T.
    Dats, L.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S253 - S253
  • [39] 3-YEAR FOLLOW-UP OF PATIENTS WITH OSA ON TELEMONITORING
    Guimaraes, Maria
    Silva, Elisabete
    Costa, Catarina
    Silva, Andreia
    SLEEP, 2023, 46
  • [40] Mesonephric adenocarcinoma of the vagina with a 3-year follow-up
    Ersahin, Ç
    Huang, M
    Potkul, RK
    Hammadeh, R
    Salhadar, A
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 757 - 760